Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Certain genetic markers may increase or decrease prostate cancer risk.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

No link found between aromatase gene and female hair loss.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Surgery successfully treated the ferret's adrenal issue, leading to hair regrowth and improved health.

Ketoconazole improved symptoms of ACTH-independent Cushing syndrome despite inconclusive initial scans.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Six months after COVID-19, most patients still had autoantibodies.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Patients with thyroid disorders show different symptoms and antibody levels.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Men with androgenetic alopecia have lower levels of certain proteins and more cell damage.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.